FDA Revises Prescriber DTC Survey To Focus On Patient Interactions
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency appeared unusually receptive to outside suggestions about a proposed questionnaire, dropping questions related to drug pricing and adding ones about exam room conversations.